(MENAFN - GlobeNewsWire - Nasdaq) Pune, India, Feb. 18, 2021 (GLOBE NEWSWIRE) Recent technological advancements in digital healthcare devices and equipment is expected to drive the global nanopore technologies market . The emergence of digitalization has transformed the nanopore technologies. In the process of nanopore technology sequencing, current passes nano-sized pores and are later used for protein sequencing. This sequencing information is collected in the form of electronic data. Owing to the adoption of the internet of things (IoT), this technology can be effectively employed for the sequencing of human genome. This technology has a higher preference than other technologies owing to its cost-effectiveness and quicker results. Moreover, researchers are planning to develop molecule detectors and sequencers by adopting this technology.
USD 35.94 billion by 2026, exhibiting a CAGR of 7.8% during the forecast period. Rising efforts to make cities smarter through advanced technology will pave the way for the growth of this market in the given time period. Urbanization around the globe is speeding ahead at an exponential rate owing to the movement of people from rural to urban areas. According to UN estimates, by 2050, around 68% of the world’s population will be living in urban areas. This has prompted governments in many countries to transform cities into smart cities to make governance more efficient and effective. For instance, in March 2018, the Independent reported that police authorities in Shenzhen, China have deployed facial recognition technology, using AI-based CCTV cameras to catch jaywalkers and implement traffic rules stringently. As countries develop, the demand for digital signage solutions is likely to spike and this will be one of the leading digital signage market trends during the forecast period.
The global gas to liquid (GTL) market is set to gain momentum from the increasing occurrence of joint research & development for broadening the reach of GTL
By Robert Kennedy
Feb 10, 2021 3:41 AM
APPLETON, WI (WTAQ-WLUK) – For the last 11 months, UW-Oshkosh has been surveying thousands of Wisconsin businesses to help monitor the impact of COVID-19.
“Now, we’re hurting a little bit, we’re looking for more business,” said Darby Schumacher, general manager at Mr. Brews Taphouse in Appleton.
Schumacher tells FOX 11 they’ve had their share of ups and downs during the pandemic.
“Overall we are hanging in there, every week seems to keep getting a little bit better as people feel a little bit extra safe. And get better at regular life pretty soon.”
For months, the restaurant has taken part in UWO’s business survey.
Europe Prothrombin Complex Concentrate Market to Grow USD 398.9 Million at 10.9% CAGR till 2027; Rising Adoption of Advanced Bleeding Disorder Management Solutions to Fuel Growth: Fortune Business Insights™ Top Players Covered in the Europe Prothrombin Complex Concentrate Market Research Report are Takeda Pharmaceutical Company Limited (Tokyo, Japan), Kedrion S.p.A (Lucca, Italy), Grifols, S.A. (Barcelona, Spain), Sanquin (Amsterdam, The Netherlands), Octapharma AG (Lachen, Switzerland), CSL Limited (Melbourne, Australia) and other key market players.
February 09, 2021 04:48 ET | Source: Fortune Business Insights Fortune Business Insights
Pune, India, Feb. 09, 2021 (GLOBE NEWSWIRE) The
Europe prothrombin complex concentrate market size is projected to reach USD 398.9 million by 2027, exhibiting a CAGR of 10.9% during the forecast period. The substantial advantages offered by prothrombin complex concentrate (PCC) will be the prim